Tangen Biosciences

780 East Main Street, Suite 1
Branford, CT 06405

Phone: 203.433.4045
Fax: 203.643.2292
Website: http://tangenbio.com

Email: rick.birkmeyer@tangenbio.com

General Information:

Tangen was founded in 2013 and is located in Branford, Connecticut. The Company has developed an innovative platform that enables molecular diagnostic technology to move out of traditional laboratories by providing low cost, portable, and rapid diagnostic capabilities for a variety of applications. There is currently an unmet need in the market for truly flexible nucleic acid-based diagnostic devices, which Tangen’s platform, the Tangen Molecular Diagnostic System (TangenDx™), is designed to fill. What sets TangenDx™ apart from competitors is the capability to detect a broad array of targets simultaneously on a single sample, while maintaining low cost, easy workflow, and extreme sensitivity. Tangen believes that this is the future of diagnostics, and a technology such as the TangenDx™ will eventually bring high quality molecular testing to the traditional laboratory setting, and also to settings outside the laboratory, such as clinics, doctor’s offices, pharmacies, and even into the hands of rural health care providers in less developed regions of the world.

Research Activities:

Tangen Biosciences is continuing to improve the features and capabilities of the TangenDx platform technology. New assay development is as simple as designing customized solutions for sample type and species. Tangen currently has a USG contract to utilize the TangenDx in the design and manufacture of a highly sensitive blood test to diagnose infections occurring in a bioterrorism event involving Anthrax exposure. Future assays will include highly sensitive tests to identify antibiotic sensitivity directly from a patient blood sample, in less than an hour, with no need for accessory equipment, reagent refrigeration, and with minimal training.